Pharmaco - Press Releases

Date	Title	Company
10-Feb-2023	BRAIN Biotech AG terminates contract for natural sweetener solution with Roquette Frères	BRAIN Biotech AG
10-Feb-2023	Belano Medical AG: Golden Beauty Award for ibiotics skin care from BELANO medical	Belano Medical AG
10-Feb-2023	Evotec receives € 150 m loan from European Investment Bank	Evotec SE
09-Feb-2023	Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation	Fresenius Medical Care AG & Co. KGaA
09-Feb-2023	Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation	Fresenius SE & Co. KGaA
09-Feb-2023	Invitation: Straumann Group 2022 full-year results webcast	Straumann Holding AG
09-Feb-2023	Biotest AG: Biotest significantly exceeds EBIT guidance 2022	Biotest AG
09-Feb-2023	Evotec and Related Sciences expand integrated drug discovery and development partnership	Evotec SE
08-Feb-2023	Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon	Lonza Group AG
08-Feb-2023	Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG	Bayer Aktiengesellschaft
08-Feb-2023	Availability of Sanofi’s Nexviadyme®▼(avalglucosidase alfa) provides NHS with new treatment for Pompe disease	Sanofi
08-Feb-2023	Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting	Sartorius Stedim Biotech SA
08-Feb-2023	The new DUSA Shaker™ DTS 100i from Copley: For faster, safer, more repeatable inhaler testing	Copley Scientific
08-Feb-2023	BioSenic announces the approval and publication of the Prospectus for listing and admission to trading of the shares and subscription rights issued in the context of the capital increase by way of in kind contributions of Medsenic 51 percent participation	BioSenic
08-Feb-2023	NICE draft guidance does not recommend empagliflozin (Jardiance®) for treating symptomatic chronic heart failure with preserved or mildly reduced ejection fraction	Boehringer Ingelheim
08-Feb-2023	Santhera Concludes Agreement with French Authorities on Raxone® Reimbursement and Plans to Submit a Request for an Early Access Program for Vamorolone	Santhera
08-Feb-2023	Spinout develops open-source software for the pharmaceutical industry	Spinout OpenBioSim
08-Feb-2023	Major national testing centre to become anchor resident at PHTA	Clinical Immunology Service (CIS)
08-Feb-2023	Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in Europe	Cell and Gene Therapy Catapult
08-Feb-2023	Bayer donates 1.5 million euros for immediate aid to victims of devastating earthquakes in Türkiye and Syria	Bayer